Table of Contents: Emerging drugs and targets for alzheimer's disease.

Other Authors:	Martinez, Ana.
Format:	Book
Language:	English
Published:	Cambridge, Royal Society of Chemistry, 2010.
Subjects:	Neurology & clinical neurophysiology. Pharmacology.
Online Access:	http://dx.doi.org/10.1039/9781849731065

Table of Contents:

Beta-Amyloid as target
Chapter 1: The amyloid hypothesis of AD and prospects for therapeutics
Chapter 2: Targeting Alzheimer's ?-Secretase: Genetic and Chemical Modulation
Chapter 3: Cholesterol and AD: the molecules, the targets
Chapter 4: The Bimodal Features of Butyrylcholinesterase in Cholinergic Neurotransmission and Amyloid Suppression
Chapter 5: Scyllo-inositol, a potential therapy for Alzheimer's disease
Chapter 6: Immunotherapeutic strategies toward treatment of AD
Tau protein as target
Chapter 7: Alzheimer Neurofibrillary Degeneration: Pivotal Role and Therapeutic Targets
Chapter 8: Multiple roles of glycogen synthase kinase-3 in AD
Chapter 9: Tau protein kinases inhibitors: from the bench to the clinical trials
Chapter 10: Activating PP2A as a therapeutic intervention strategy in AD
Chapter 11: Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies
Glucose Metabolism as target
Chapter 12: Insulin Insulin Resistance and neurodegeneration: Type 2 versus type 3 diabetes mellitus
Chapter 13: Insulin-like Growth Factor I as a disease-modifying therapy in Alzheimer's disease
Chapter 14: Ketone bodies as a therapeutic for Alzheimer's disease.